# Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate Cancer

> **NCT06220435** · NA · RECRUITING · sponsor: **Region Skane** · enrollment: 76 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Ultra-hypofractionated radiotherapy regimen.

## Key facts

- **NCT ID:** NCT06220435
- **Lead sponsor:** Region Skane
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-25
- **Primary completion:** 2031-09-01
- **Final completion:** 2031-09-01
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06220435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06220435, "Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06220435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*